HXLPE Vs CPE Cups Under 50 Years
Wear Resistance of Highly Crosslinked Cemented Polyethylene Cups in Young Patients
1 other identifier
interventional
59
0 countries
N/A
Brief Summary
This randomized controlled trial evaluated the long-term wear of cemented highly cross-linked polyethylene (HXLPE) versus conventional polyethylene (CPE) acetabular cups in patients under 50 years undergoing primary total hip arthroplasty (THA). All surgeries were performed at Radboud University Medical Center by three surgeons using a posterolateral approach. Acetabular components included either highly cross-linked polyethylene (HXLPE) cups (X3 RimFit) or conventional polyethylene (CPE) cups (Exeter Contemporary Flanged). Both were implanted with bone cement, and femoral components consisted of Exeter V40 stems with 28 mm cobalt-chromium heads. Impaction bone grafting (IBG) was routinely used, with mesh applied in cases of acetabular bone defects. Radiographs were taken preoperatively and at 10-year follow-up using standardized protocols. Polyethylene wear was assessed with PolyWare software, creating 3D models from baseline and 10-year radiographs to calculate linear and volumetric wear. Cup inclination and osteolysis were evaluated in three acetabular zones (DeLee and Charnley classification).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Oct 2010
Longer than P75 for phase_4
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2023
CompletedFirst Submitted
Initial submission to the registry
November 21, 2024
CompletedFirst Posted
Study publicly available on registry
November 26, 2024
CompletedNovember 26, 2024
November 1, 2024
12.4 years
November 21, 2024
November 22, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Linear wear (mm/y)
10 years
Volumetric wear (mm3/y)
10 years
Secondary Outcomes (1)
Cup survival (%)
10 years
Study Arms (2)
Control group
ACTIVE COMPARATORIntervention group
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- primary THA
- age under 50 years
You may not qualify if:
- THA due to an oncological condition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 21, 2024
First Posted
November 26, 2024
Study Start
October 1, 2010
Primary Completion
February 28, 2023
Study Completion
July 1, 2023
Last Updated
November 26, 2024
Record last verified: 2024-11